On Wednesday, Koninklijke Philips NV (ADR) (NYSE:PHG)’s shares declined -0.46% to $26.19.
Koninklijke Philips NV (ADR) (PHG) believes in remaining true to its tagline, “Innovation and You.” As part of its efforts to simplify the life of customers, the company’s business unit Philips Respironics launched the Amara View CPAP mask to enhance the experience of CPAP patients.
Inside the Headlines
Amara View CPAP mask is a full-face mask that offers patients with widest field vision in addition to minimum contact with skin. Philips has ingeniously modified the mask’s under-the-nose design to overcome the problem of red marks and irritation, a common feature for CPAP patients. Apart from this, the small size of the mask marks a considerable improvement over the bulky cushion and frame present in traditional masks, thereby allowing patients to easily read books, wear glasses and watch television.
Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, counting radiation oncology and portfolio administration; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products.
Dunkin Brands Group Inc (NASDAQ:DNKN)’s shares dropped -0.38% to $55.52.
Dunkin Brands Group Inc (DNKN) declared the kick-off of a sweepstakes in partnership with Liverpool FC (LFC), one of the world’s most historic and famous football clubs. The sweepstakes will give fans in Vietnam the chance to score the ultimate LFC fan experience during the club’s forthcoming summer Southeast Asia tour and also celebrate Dunkin’ Donuts’ wide range of delicious coffees and baked goods.
From now through July 4th, Dunkin’ Donuts guests in Vietnam can earn an entry into the sweepstakes when they purchase a half dozen donuts. One lucky grand prize winner will receive a trip for two to Kuala Lumpur, Malaysia with three nights hotel accommodation, two tickets to the LFC match against Malaysia XI on July 24th in Kuala Lumpur, two tickets to an LFC training session and two tickets to an exclusive meet and greet with LFC players.
Dunkin Brands Group, Inc., together with its auxiliaries, develops, franchises, and licenses quick service restaurants under the Dunkin Donuts and Baskin-Robbins brands worldwide. The company operates through four segments: Dunkin’ Donuts U.S., Dunkin’ Donuts International, Baskin-Robbins U.S., and Baskin-Robbins International.
At the end of Wednesday’s trade, GulfMark Offshore, Inc. (NYSE:GLF)‘s shares dipped -6.61% to $10.18.
GulfMark Offshore, Inc. (GLF) declared that its second quarter 2015 earnings conference call is planned for Thursday, July 23, 2015, at 9:00 a.m. eastern daylight time. The call will be hosted by Quintin Kneen, President and Chief Executive Officer; Jay Mitchell, Executive Vice President and Chief Financial Officer; and David Rosenwasser, Senior Executive Vice President and Chief Operating Officer. The Company will issue earnings results for the second quarter the evening before the planned call.
GulfMark Offshore, Inc. provides offshore marine support and transportation services primarily to the companies involved in the offshore exploration and production of oil and natural gas. The company’s vessels offer various services supporting the construction, positioning, and ongoing operation of offshore oil and natural gas drilling rigs and platforms, and related infrastructure.
EXACT Sciences Corporation (NASDAQ:EXAS), ended its Wednesday’s trading session with -1.17% loss, and closed at $28.70.
Exact Sciences Corp. (EXAS) declared that the company will host webcasts and conference calls to talk about its second-quarter 2015 financial results and of its annual stockholders meeting.
Date: Monday, July 20, 2015
Time: 10 a.m. ET, 9 a.m. CT
Webcast: The live webcast can be accessed at www.exactsciences.com
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test comprises proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
